Cytori Therapeutics reported $3.93M in Operating Expenses for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Baxter International BAX:US $ 3544M 376M
Cerus CERS:US $ 52.87M 4.18M
Cytori Therapeutics CYTX:US $ 3.93M 13K
Dr.Reddys Laboratories DRRD:IN 53.17B 9B
Genocea Biosciences GNCA:US $ 16.04M 2.63M
Haemonetics HAE:US $ 245.8M 21.68M
Infinity Pharmaceuticals INFI:US $ 13.06M 1.11M
Merrimack Pharmaceuticals MACK:US $ 132K 341K
Mirati Therapeutics MRTX:US $ 184.93M 12.45M
Northwest Biotherapeutics NWBO:US 12.28M 1.58M
Starpharma Holdings Ltd SPL:AU 10.49M 998K
Sun Pharmaceuticals SUNP:IN IR 117596.3M 39598.1M
Teva Pharmaceutical TEVA:IT 4.37B 352M